A QSAR study confirming the heterogeneity of the HEPT derivative series regarding their interaction with HIV reverse transcriptase

Author： Tronchet J.   Grigorov M.   Dolatshahi N.   Moriaud F.   Weber J.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.32, Iss.4, 1997-01, pp. : 279-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach

By  

Medicinal Chemistry, Vol. 3, Iss. 3, 2007-05 ,pp. : 227-232

Bentham Science Publishers

Access to resources Recommend Favorite

Hybrid Canonical-Correlation Neural-Network Approach Applied to Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors (HEPT Derivatives)

By  

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1643-1659

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4165-4186

Bentham Science Publishers

Access to resources Recommend Favorite

Variable Selection Based QSAR Modeling on Bisphenylbenzimidazole as Inhibitor of HIV-1 Reverse Transcriptase

By  

Medicinal Chemistry, Vol. 9, Iss. 7, 2013-11 ,pp. : 955-967

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören   Hilgeroth Andreas  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite